Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Swelling, X-ray
Clinical narrative: Still experiencing inflammatory response like swollen gland in the neck; Joint pain; pain; swollen, tender, colored toe; swollen, tender, colored toe; Swollen knuckles; fever; experiencing swelling to the side of neck; This is a spontaneous report received from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Batch/Lot Number: EN6199), intramuscular, administered in Arm Left on 06Mar2021 10:00 as DOSE 2, SINGLE for covid-19 immunization. Patient had no medical history or concomitant medications. The patient experienced experiencing swelling to the side of neck on Mar2021 with outcome of not recovered , still experiencing inflammatory response like swollen gland in the neck (lymphadenopathy) on an unspecified date with outcome of recovered , joint pain (arthralgia) and swollen knuckles (joint swelling) on 08Mar2021 with outcome of recovering , pain on an unspecified date with outcome of recovering , fever (pyrexia) on 07Mar2021 with outcome of recovered , swollen, tender,colored toe (joint dislocation) and swollen, tender, colored toe (pain in extremity) on an unspecified date with outcome of not recovered.The patient underwent lab tests and procedures which included x-ray: covid toe on 13 feb21.   Therapeutic measures were taken as a result of experiencing swelling to the side of neck , still experiencing inflammatory response like swollen gland in the neck (lymphadenopathy), joint pain (arthralgia), swollen knuckles (joint swelling), pain , fever (pyrexia), swollen, tender, colored toe (joint dislocation), swollen, tender, colored toe (pain in extremity).   Follow up (17May2021): This is a follow-up spontaneous report from a contactable consumer.This consumer reported for herself that:she is experiencing inflammatory response like swollen gland in the neck. Batch/lot number EN6199 start date of drug reported as 06 mar2021.Date of first vaccination: Consumer stated it as 13Feb2021 but not clarified.LOT# of first vaccine: EN9581.Further probing could not be initiated as consumer was unwilling to further answer the questions. Hence, other details were unknown and limited information was available over the call.  Follow up (17May2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported for herself that included event as reported by primary source was swollen, tender, colored toe on 15Feb2021 with outcome of recovering. Event fever start date reported as 07th mar2021 and end date was reported to be 08th mar2021.Dates for swollen knuckles at the top of her hand reported to be from: 08Mar2021 To: Ongoing.Event: swollen glands in her neck that is painful and sensitive was reported as worsened. Caller mentioned in call about the side effects she has experienced in two days after the first injection she had a swollen, tender, colored toe that was described by the physician as a COVID toe. Caller stated the color has improved but has not gone away. Caller stated she went to see a Podiatrist who took an x-ray to rule out arthritis and confirmed it was also the so called COVID toe. Patient was advised to use a anti inflammatory cream for toe discoloration.Patient stated that this colored toe started after her 2nd dose that is 13th feb2021.